The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Intracellular Interleukin-1 Receptor 2 Binding Prevents Cleavage and Activity of Interleukin-1α, Controlling Necrosis-Induced Sterile Inflammation
Open accessAbstract
Necrosis can induce profound inflammation or be clinically silent. However, the mechanisms underlying such tissue specificity are unknown. Interleukin-1α (IL-1α) is a key danger signal released upon necrosis that exerts effects on both innate and adaptive immunity and is considered to be constitutively active. In contrast, we have shown that necrosis-induced IL-1α activity is tightly controlled in a cell type-specific manner. Most cell types examined expressed a cytosolic IL-1 receptor 2 (IL-1R2) whose binding to pro-IL-1α inhibited its cytokine activity. In cell types exhibiting a silent necrotic phenotype, IL-1R2 remained associated with pro-IL-1α. Cell types possessing inflammatory necrotic phenotypes either lacked IL-1R2 or had activated caspase-1 before necrosis, which degraded and dissociated IL-1R2 from pro-IL-1α. Full IL-1α activity required cleavage by calpain after necrosis, which increased its affinity for IL-1 receptor 1. Thus, we report a cell type-dependent process that fundamentally governs IL-1α activity postnecrosis and the mechanism allowing conditional release of this blockade.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Indeed, necrotic VSMCs potently drive inflammation via IL1α due to a lack of IL-1R2 that normally binds and inhibits IL-1α 133,189 .”
From Vascular smooth muscle cells in atherosclerosis (2019) · cites this paper as [189]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tolerance, Danger, and the Extended Family
Matzinger, P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.005015 · Cited by 4,848 · cited 1×
“The ‘‘danger’’ model proposes that immunity responds to nonphysiological cell death, damage, or stress (Matzinger, 1994).”
Biologic basis for interleukin-1 in disease.
Dinarello, C. (1996) · Blood · doi:10.1182/blood.v87.6.2095.bloodjournal8762095 · Cited by 4,344 · cited 2×
“Indeed, increased IL-1 activity is a hallmark of many chronic inflammatory conditions, including rheumatoid arthritis, gout, diabetes, atherosclerosis, and psoriasis (Dinarello, 1996, 2009; Duewell et al., 2010; Rajamäki et al., 2010).”
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
Scaffidi, P., Misteli, T., & Bianchi, M. E. (2002) · Nature · doi:10.1038/nature00858 · Cited by 4,221
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., et al. (2010) · Nature · doi:10.1038/nature08938 · Cited by 4,026 · cited 2×
“Indeed, increased IL-1 activity is a hallmark of many chronic inflammatory conditions, including rheumatoid arthritis, gout, diabetes, atherosclerosis, and psoriasis (Dinarello, 1996, 2009; Duewell et al., 2010; Rajamäki et al., 2010).”
Immunological and inflammatory functions of the interleukin-1 family
Dinarello, C. A. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132612 · Cited by 3,466 · cited 11×
“IL-1a is near universally expressed (Dinarello, 2009), lacks a signal peptide, is rarely extracellular under normal physiology, and also associates with chromatin during apoptosis, resulting in retention (Cohen et al.”
InfluentialSterile inflammation: sensing and reacting to damage
Chen, G. Y., & Nuñez, G. (2010) · Nature Reviews Immunology · doi:10.1038/nri2873 · Cited by 3,051 · cited 4×
“Many human diseases are driven by activation of these pathways, including ischemia-reperfusion injury, Alzheimer’s disease, atherosclerosis, and toxic insults to liver and lung (Chen and Nuñez, 2010; Kono and Rock, 2008; Stewart et al., 2010).”
InfluentialGhiringhelli, F., Apetoh, L., Tesniere, A., Aymeric, L., Ma, Y., Ortiz, C., Vermaelen, K., Panaretakis, T., Mignot, G., Ullrich, E., et al. (2009) · Nature Medicine · doi:10.1038/nm.2028 · Cited by 1,898 · cited 1×
“Induction of antitumor immunity in vivo is dependent upon the mode of cell death, whereby necrosis is more immunogenic than apoptosis (Melcher et al., 1998) and local IL-1 activity (Ghiringhelli et al., 2009; Michaud et al., 2011).”
How dying cells alert the immune system to danger
Kono, H., & Rock, K. L. (2008) · Nature Reviews Immunology · doi:10.1038/nri2215 · Cited by 1,737 · cited 6×
“Many human diseases are driven by activation of these pathways, including ischemia-reperfusion injury, Alzheimer’s disease, atherosclerosis, and toxic insults to liver and lung (Chen and Nuñez, 2010; Kono and Rock, 2008; Stewart et al., 2010).”
InfluentialAltered Cytokine Export and Apoptosis in Mice Deficient in Interleukin-1β Converting Enzyme
Kuida, K., Lippke, J. A., Ku, G., Harding, M. W., Livingston, D. J., Su, M. S. S., & Flavell, R. A. (1995) · Science · doi:10.1126/science.7535475 · Cited by 1,631 · cited 1×
“Indeed, expression of an uncleavable IL-1R2 mutant reduces IL-1a release, whereas Casp1 / mice have long been known to be deficient in IL-1a secretion (Kuida et al., 1995; Li et al., 1995).”
Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs
March, C. J., Mosley, B., Larsen, A., Cerretti, D. P., Braedt, G., Price, V. L., Gillis, S. A., Henney, C. S., Kronheim, S. R., Grabstein, K. H., et al. (1985) · Nature · doi:10.1038/315641a0 · Cited by 1,559 · cited 4×
“, 2003), and cytokine activity is supposedly independent of cleavage (March et al., 1985; Mosley et al., 1987).”
Influential
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 206
IL-1 Receptor Dynamics in Immune Cells: Orchestrating Immune Precision and Balance
Kim, D. H., & Lee, W. (2024) · Immune Network · doi:10.4110/in.2024.24.e21 · Cited by 31
“In infectious conditions, active caspase-1 cleaves IL-1R2, which causes dissociation from IL-1 α , calpain processing, and complete restoration of IL-1 α activity after necrosis (35).”
BackgroundSulik, A., Kroteń, A., Wojtkowska, M., & Ołdak, E. (2013) · Scandinavian Journal of Immunology · doi:10.1111/sji.12131 · Cited by 31
Membrane Association Dictates Ligand Specificity for the Innate Immune Receptor NOD2
Schaefer, A. K., Melnyk, J. E., Baksh, M. M., Bersch, K. L., Finn, M. G., & Grimes, C. L. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.7b00469 · Cited by 34
Beyond canonical inflammasomes: emerging pathways in IL-1-mediated autoinflammatory disease
Lukens, J. R., & Kanneganti, T. (2014) · Seminars in Immunopathology · doi:10.1007/s00281-014-0434-8 · Cited by 30
Interleukin‐1 as a pharmacological target in acute brain injury
Brough, D., Rothwell, N. J., & Allan, S. M. (2015) · Experimental Physiology · doi:10.1113/ep085135 · Cited by 31
“2013), processing increases its activity (Afonina et al. 2011; Zheng et al. 2013).”
Almog, T., Kandel-Kfir, M., Levkovich, H., Shlomai, G., Barshack, I., Stienstra, R., Lustig, Y., Leikin-Frenkel, A. I., Harari, A., Bujanover, Y., et al. (2019) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-000650 · Cited by 26
Grytting, V. S., Refsnes, M., Øvrevik, J., Halle, M. S., Schönenberger, J., van der Lelij, R., Snilsberg, B., Skuland, T., Blom, R., & Låg, M. (2021) · Particle and Fibre Toxicology · doi:10.1186/s12989-021-00409-y · Cited by 25
Kumar, V., Everingham, S., Hall, C., Greer, P. A., & Craig, A. W. (2013) · European Journal of Immunology · doi:10.1002/eji.201343757 · Cited by 26
Zhang, Y., Zhang, C., Yang, Y., Wang, G., Wang, Z., Liu, J., Zhang, L., & Yu, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.862493 · Cited by 28
Cobalt Chloride Induces Necroptosis in Human Colon Cancer HT-29 Cells
Wang, H., & Zhang, B. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.6.2569 · Cited by 24
“Furthermore necrosis is always associated with ensuing inflammation reaction (Zheng et al., 2013).”
Burzynski, L. C., Humphry, M., Bennett, M. R., & Clarke, M. C. H. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.667915 · Cited by 23
“Treatment of EL4 cells with necrotic VSMC lysates as a positive control (10) resulted in high levels of IL-2 production ( 8000 200 pg/ml) (Fig.”
BackgroundMethodInfluentialSelf-citationStassi, A. F., Baravalle, M. E., Belotti, E. M., Amweg, A. N., Angeli, E., Velázquez, M. M. L., Rey, F., Salvetti, N. R., & Ortega, H. H. (2018) · Theriogenology · doi:10.1016/j.theriogenology.2017.12.048 · Cited by 23
Thrombin: Coagulation's master regulator of innate immunity
Conway, E. M. (2019) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14586 · Cited by 22
Monocyte-macrophage membrane expression of IL-1R2 is a severity biomarker in sepsis
Supino, D., Davoudian, S., Silva-Gomes, R., Piovani, D., Garuti, R., Desai, A., Mapelli, S. N., Scavello, F., Carnevale, S., Mariancini, A., et al. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07597-x · Cited by 21
Interleukin-1 receptor antagonist: a promising cytokine against human squamous cell carcinomas
Ding, Y., Yi, J., Wang, J., & Sun, Z. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e14960 · Cited by 21
“For instance, SIL1R2 was reported to have a high affinity to the precursor of IL-1 and inhibit its processing on caspase-1 [31].”
Liu, Y., Wang, Y., Shi, H., Jia, L., Cheng, J., Cui, W., Li, H., Li, Y., & Du, J. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv211 · Cited by 21
“Previous studies showed that IL-1a was a key danger signal released on primary necrosis of vascular SMCs and induced IL-6 and MCP-1 production by binding to IL-1 receptor 1.(41,42) DAMPs, such as the heat shock protein and high-mobility group box 1, could induce inflammation by activating PRR TLR4,(40) and TLR4 was re…”
Induction of the IL-1RII decoy receptor by NFAT/FOXP3 blocks IL-1β-dependent response of Th17 cells
Kim, D. H., Kim, H. Y., Cho, S., Yoo, S.-J., Kim, W., Yeon, H. R., Choi, K., Choi, J., Kang, S. W., & Lee, W. (2021) · eLife · doi:10.7554/elife.61841 · Cited by 21
“DOI: https://doi.org/10.7554/eLife.61841 14 of 29 maturation and influences necrosis-induced sterile inflammation (Zheng et al., 2013).”
BackgroundInfluentialPyroptosis and neurological diseases
Zhao, G., & Xie, Z. (2014) · Neuroimmunology and Neuroinflammation · doi:10.4103/2347-8659.139716 · Cited by 19
“indirect protective effect (s) by influencing IL-1R2 and caspase-1 dependent nonclassical secretion system.[58,59]”
BackgroundTan, C., Ma, H., Chen, J., Ma, G., Jha, A., Tan, S., Zhu, Y., Liu, M., Liu, K., Xiao, X., et al. (2025) · Advanced Science · doi:10.1002/advs.202502297 · Cited by 18
Narros‐Fernández, P., Basavarajappa, S. C., & Walsh, P. T. (2023) · FEBS Journal · doi:10.1111/febs.16888 · Cited by 19
“Although the full-length form of IL-1 a accounts for signalling functions itself, the processing of IL-1 a by calpain results in a 17-kDa fragment that shows an increased affinity for its receptor [78,79].”
BackgroundIL-1 Contributes to the Anti-Cancer Efficacy of Ingenol Mebutate
Le, T. T., Skak, K., Schroder, K., Schroder, W. A., Boyle, G. M., Pierce, C. J., & Suhrbier, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153975 · Cited by 18
Interleukin-1 regulates follicular T cells during the germinal center reaction
Belbézier, A., Engeroff, P., Fourcade, G., Vantomme, H., Vaineau, R., Gouritin, B., Bellier, B., Brochériou, I., Tchitchek, N., Graff‐Dubois, S., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1393096 · Cited by 15
Yang, R., Chen, X., Dewamitta, S. R., Sakai, S., Tsuchiya, K., Hara, H., Shen, Y., Qu, H., Fang, R., Mitsuyama, M., et al. (2013) · Pathogens and Disease · doi:10.1111/2049-632x.12075 · Cited by 17
Lee, H.-J., Cheong, K. A., Kim, J., Kim, N.-H., Noh, M., & Lee, A. (2018) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2017.167 · Cited by 17
“However, the role of IL-1ra in cell survival by IL-1 antagonism has not been presented for skin keratinocytes, but in cells residing in different organs damaged by, for example, acute pancreatitis, hepatic failure, or ischemic heart disease (Fink and Norman, 1997; Vecile et al., 2013; Zheng et al., 2013).”
BackgroundSenescence utilises inflammatory caspases to drive SASP
Wiggins, K. A., & Clarke, M. C. H. (2019) · Aging · doi:10.18632/aging.102031 · Cited by 17
Self-citationMufazalov, I. A., Regen, T., Schelmbauer, C., Kuschmann, J., Muratova, A. M., Nikolaev, A., Müller, W., Pinteaux, E., & Waisman, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161505 · Cited by 16
Martin, S. J., Frezza, V., Davidovich, P. B., Najda, Z., & Clancy, D. M. (2022) · Cytokine · doi:10.1016/j.cyto.2022.155935 · Cited by 16
IL-1 signaling pathway, an important target for inflammation surrounding in myocardial infarction
Huang, J., Kuang, W., & Zhou, Z. (2024) · Inflammopharmacology · doi:10.1007/s10787-024-01481-4 · Cited by 17
“It prevents the cleavage and activity of interleukin-1α and controls necrosis-induced sterile inflammation (Zheng et al. 2013).”
Acid-dependent Interleukin-1 (IL-1) Cleavage Limits Available Pro-IL-1β for Caspase-1 Cleavage
Edye, M. E., Brough, D., & Allan, S. M. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.667162 · Cited by 15
“Pro-IL-1 is cleaved via calcium-dependent cysteine proteases of the calpain family to produce 17-kDa IL-1 (10).”
BackgroundObar, J. J., Hohl, T. M., & Cramer, R. A. (2016) · Cytokine · doi:10.1016/j.cyto.2016.05.015 · Cited by 15
Niu, F., Wang, T., Li, J., Yan, M., Li, D.-Z., Li, B., & Jin, T. (2018) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.516 · Cited by 15
Ni, H., Hu, X., Yang, N., Liu, X., Cai, W., Zhong, R., Wang, T., Yu, M., & Tang, S. (2024) · Toxicological Research · doi:10.1007/s43188-024-00229-0 · Cited by 14
“Although the canonical NLRP3 inflammasome does not incorporate IL-1α, it has been reported that upon NLRP3 inflammasome activation, Caspase-1 has the ability to cleave IL-1 receptor 2 and liberate pro-IL-1α for maturation processing and secretion [39].”
Fasting Induces IL-1 Resistance and Free-Fatty Acid-Mediated Up-Regulation of IL-1R2 and IL-1RA
Joesting, J. J., Moon, M. L., Gainey, S. J., Tisza, B. L., Blevins, N. A., & Freund, G. G. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00315 · Cited by 14
“More recently, sIL1R2 has been shown to complex with the pro-IL-1α inhibiting its enzymatic maturation by calpain (53).”
BackgroundMutations in components of antiviral or microbial defense as a basis for breast cancer
Friedenson, B. (2013) · Functional & Integrative Genomics · doi:10.1007/s10142-013-0336-1 · Cited by 14
Fang, R., Wu, R., Du, H., Jin, M., Liu, Y., Lei, G., Jiang, B., Lei, Z., Peng, Y., Nie, K., et al. (2017) · Infection and Immunity · doi:10.1128/iai.00201-17 · Cited by 14
Chan, J. N. E., Humphry, M., Kitt, L., Krzyzanska, D., Filbey, K. J., Bennett, M. R., & Clarke, M. C. H. (2020) · European Journal of Immunology · doi:10.1002/eji.201948521 · Cited by 15
Self-citationSuárez-López, L., Shui, B., Brubaker, D. K., Hill, M., Bergendorf, A. M., Changelian, P. S., Laguna, A., Starchenko, A., Lauffenburger, D. A., & Haigis, K. M. (2021) · iScience · doi:10.1016/j.isci.2021.103406 · Cited by 13
Interleukin-1 signaling in solid organ malignancies
Dosch, A. R., Singh, S. P., Nagathihalli, N. S., Datta, J., & Merchant, N. B. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188670 · Cited by 14
Zhang, Y., Liu, K., Guo, M., Yang, Y., & Zhang, H. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112400 · Cited by 15
Interleukin-1 Receptor 2 Keeps the Lid on Interleukin-1α
Paolo, N. C. D., & Shayakhmetov, D. M. (2013) · Immunity · doi:10.1016/j.immuni.2013.02.001 · Cited by 13
Zheng, J., Dong, H., Zhang, T., Ning, J., Xu, Y., & Cai, C. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.865052 · Cited by 13
“In aseptic inflammation caused by necrosis, IL1R2 can also be used as an inhibitor of intracellular pro-IL1 α (Zheng et al., 2013).”
BackgroundThe importance of the IL ‐1 family of cytokines in nanoimmunosafety and nanotoxicology
Zhang, G., Luo, W., Yang, W., Li, S., Li, D., Zeng, Y., & Li, Y. (2022) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1850 · Cited by 13
Cardiac arrhythmia in COVID‐19 patients
Yu, L., Liu, Y., & Feng, Y. (2024) · Annals of Noninvasive Electrocardiology · doi:10.1111/anec.13105 · Cited by 13
Expression and regulation of alarmin cytokine IL-1α in human retinal pigment epithelial cells
Bian, Z.-M., Field, M. G., Elner, S. G., & Elner, V. M. (2018) · Experimental Eye Research · doi:10.1016/j.exer.2018.03.015 · Cited by 13
“IL-1RII, another cytosolic IL-1 receptor, is also expressed in hRPE cells (Leung et al., 2009), whose binding is thought to inhibit proIL-1α activity (Burzynski et al., 2015; Zheng et al., 2013).”
Burzynski, L. C., Morales-Maldonado, A., Rodgers, A., Kitt, L., Humphry, M., Figg, N. L., Bennett, M. R., & Clarke, M. C. H. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvad091 · Cited by 12
“25 Multiple studies find that IL-1 signalling drives plaque growth, 26–36 suggesting a consensus for a proatherogenic role of IL-1.”
BackgroundSelf-citationPyrillou, K., Humphry, M., Kitt, L., Rodgers, A., Nus, M., Bennett, M. R., Smith, K. G. C., Lyons, P., Mallat, Z., & Clarke, M. C. H. (2024) · JCI Insight · doi:10.1172/jci.insight.174005 · Cited by 12
“IL-1R2 is suggested to inhibit IL-1 signaling by competing with IL-1R1 for IL-1 at the cell surface, binding of IL-1 to soluble IL-1R2, and competing IL-1RAcP away from IL-1R1; additionally, an intracellular form of IL-1R2 prevents IL-1 α activation (5, 6).”
BackgroundSelf-citationInflammasomes in epithelial innate immunity: front line warriors
Robinson, K. S., & Boucher, D. (2024) · FEBS Letters · doi:10.1002/1873-3468.14848 · Cited by 12
Leinardi, R., Pochet, A., Uwambayinema, F., Yakoub, Y., Quesniaux, V. F. J., Ryffel, B., Brož, P., Pavan, C., & Huaux, F. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03463-x · Cited by 12
“The Ca2+-activated protease calpain, associated to the plasmatic cell membrane or in the cytosol of many cell types, including macrophages, canonically cleaves proIL-1α into the mature IL-1α form (17 kDa) after necrotic stimuli (Carruth et al. 1991; Kobayashi et al. 1990; Zheng et al. 2013).”
BackgroundInterleukin-1α: Novel functions in cell senescence and antiviral response
Frisch, S. M. (2022) · Cytokine · doi:10.1016/j.cyto.2022.155875 · Cited by 11
Almansouri, M., Patel, P., Chamberlain, J., & Francis, S. (2022) · Vascular Biology · doi:10.1530/vb-22-0009 · Cited by 11
Li, H., Yang, H., Ma, B., Qiao, J., Chen, F., Wang, P., Yu, R., Sun, J., & Chen, Y. (2025) · Journal of Materials Chemistry B · doi:10.1039/d5tb00474h · Cited by 12
Necrosis-Induced Sterile Inflammation Mediated by Interleukin-1α in Retinal Pigment Epithelial Cells
Liu, Y., Kimura, K., Orita, T., & Sonoda, K.-H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144460 · Cited by 11
“IL-1α activity is controlled in a cell type–specific manner [23].”
BackgroundInfluentialJiménez-García, L., Través, P. G., López-Fontal, R., Herránz, S., Higueras, M. Á., Heras, B. D. L., Hortelano, S., & Luque, A. (2016) · Biochemical Journal · doi:10.1042/bcj20160343 · Cited by 10
Baldauf, C. K., Fahldieck, C., Angenstein, A., Weinert, S., Hakobyan, M., Lipka, D. B., Haage, T. R., Bhuria, V., Böttcher, M., Mougiakakos, D., et al. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02358-x · Cited by 9
Almog, T., Kandel-Kfir, M., Shaish, A., Dissen, M., Shlomai, G., Voronov, E., Apte, R. N., Harats, D., & Kamari, Y. (2015) · Cytokine · doi:10.1016/j.cyto.2015.01.029 · Cited by 8
Wang, C., Chen, Y., Yin, X., Xu, R., Ruze, R., Song, J., Hu, C., & Zhao, Y. (2024) · Journal of Pancreatology · doi:10.1097/jp9.0000000000000175 · Cited by 7
“[38] At the same time, some studies have preliminarily identified the role of IL1R2 in the development of cancers.”
ResultMcFarlin, B., Bridgeman, E. A., Curtis, J. H., Vingren, J., & Hill, D. W. (2024) · Methods · doi:10.1016/j.ymeth.2024.07.013 · Cited by 6
Croci, D. M., Wanderer, S., Strange, F., Grüter, B. E., Casoni, D. C., Sivanrupan, S., Widmer, H. R., Santo, S. D., Fandino, J., Mariani, L., et al. (2019) · Brain Sciences · doi:10.3390/brainsci9100249 · Cited by 8
Role of Interleukin 1 Receptor 2 in Kidney Disease
Hu, H., Wu, A., Mu, X., & Zhou, H. (2024) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2023.0172 · Cited by 7
“In addition, there is an intracellular IL-1R2 that blocks the maturation of intracellular IL-1 a precursor (pro-IL-1 a ), and this effect is lost by specific cleavage of IL-1R2 by activated IL-1 converting enzyme (caspase-1) (Zheng et al., 2013).”
Carlsen, T. G., Kjærsgaard, P., Jørgensen, T. L., Foldbjerg, R., Lausen, M., Poulsen, T. B. G., Zabieglo, K., Christiansen, G., & Birkelund, S. (2015) · Journal of Immunological Methods · doi:10.1016/j.jim.2015.03.025 · Cited by 7
Li, N., Hao, Z., Yang, H., Cai, J., Liu, M., He, J., Gao, R., Shen, Y., Chen, Z., Lu, Y., et al. (2026) · Circulation · doi:10.1161/circulationaha.125.076426 · Cited by 6
Almog, T., Keshet, R., Kandel-Kfir, M., Shaish, A., Apte, R., Harats, D., & Kamari, Y. (2023) · Cytokine · doi:10.1016/j.cyto.2023.156212 · Cited by 6
Morales-Maldonado, A., Humphry, M., Figg, N. L., & Clarke, M. C. H. (2023) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2023.117308 · Cited by 6
Self-citationBeyond Negative Regulation: IL‐1R8 and IL‐1R2 as Novel Immune Checkpoints
Supino, D., Garuti, R., & Garlanda, C. (2025) · European Journal of Immunology · doi:10.1002/eji.70050 · Cited by 6
Targeting interleukin-1 signaling for renoprotection
Bogdanova, D. A., Samsonov, M. Y., Lebedeva, S. A., Bukhanova, D., Materenchuk, M. Y., & Mutig, K. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1591197 · Cited by 5
Garlanda, C., & Jaillon, S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.10001-3 · Cited by 5
Chen, B., Li, G., Fang, Q., Ding, P., & Gao, Y. (2026) · Inflammation and Regeneration · doi:10.1186/s41232-026-00416-6 · Cited by 5
“During cell necrosis, IL-1α is passively released into the extracellular environment, where it rapidly activates neighboring cells and amplifies the inflammatory cascade [102].”
Prologue: About DAMPs, PAMPs, and MAMPs
Land, W. G. (2018) · Springer eBooks · doi:10.1007/978-3-319-78655-1_11 · Cited by 5
Lubarski, K., Mania, A., Małecki, P., Mazur‐Melewska, K., & Figlerowicz, M. (2022) · Journal of Child Neurology · doi:10.1177/08830738221106663 · Cited by 4
“In the latter, neopterin reflected the fever duration and disease course, whereas CRP level did not.(32,33) Neopterin, as a sensitive cell-mediated Th1-dependent immunologic pathway marker, appears promptly after infection of mainly viral etiology.”
BackgroundTherapeutic targeting of inflammasome signaling by blocking interleukin-1
Coll, R. C. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91802-2.00010-4 · Cited by 3
Zhou, N., Liu, L., & Li, Q. (2023) · Experimental Eye Research · doi:10.1016/j.exer.2023.109750 · Cited by 4
TLR2-dependent and independent pyroptosis in dTHP-1 cells induced by Actinomyces oris MG-1
Wu, Z., Takigawa, H., Maruyama, H., Nambu, T., Mashimo, C., & Okinaga, T. (2024) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2024.101680 · Cited by 4
“Therefore, the upregulation of IL-1R2 is perceived as a negative feedback mechanism [21].”
BackgroundCRISPR/Cas9 mediated mutation of mouse IL-1α nuclear localisation sequence abolishes expression
Daniels, M. J. D., Adamson, A. D., Humphreys, N. E., & Brough, D. (2017) · Scientific Reports · doi:10.1038/s41598-017-17387-x · Cited by 4
Bone Marrow-Derived IL-1Ra Increases TNF Levels Poststroke
von Linstow, C. U., Hindkjær, S. M., Nielsen, P. V., Degn, M., Lambertsen, K. L., Finsen, B. R., & Clausen, B. H. (2021) · Cells · doi:10.3390/cells10040956 · Cited by 4
“Here, we show by qPCR that BM cells, which have infiltrated the neural parenchyma [11], significantly downregulate a panel of harmful stroke-related mRNAs such as Arg, a marker of poor functional outcome and stroke severity [54], Cxcr2, which plays a role in immune cell trafficking during inflammation [55,56], Fpr1, w…”
Hyper-induction of IL-6 after TLR1/2 stimulation in calves with bovine respiratory disease
Reid, C., Donlon, J. D., Rémot, A., Kennedy, E., MATTEIS, G. D., O’Farrelly, C., McAloon, C. G., & Meade, K. G. (2024) · PLoS ONE · doi:10.1371/journal.pone.0309964 · Cited by 3
Sakrajda, K., Bilska, K., Czerski, P. M., Narożna, B., Dmitrzak‐Węglarz, M., Heilmann‐Heimbach, S., Brockschmidt, F. F., Herms, S., Nöthen, M. M., Cichon, S., et al. (2023) · Psychopharmacology · doi:10.1007/s00213-023-06505-5 · Cited by 3
“On the other hand, the pro-IL1A interaction with inhibitory IL1R2 receptor may reduce or even prevent inflammation (Chen et al. 2007; Zheng et al. 2013; Di Paolo and Shayakhmetov 2016).”
BackgroundEndogenous DAMPs, Category III: Inducible DAMPs (Cat. III DAMPs)
Land, W. G. (2018) · Springer eBooks · doi:10.1007/978-3-319-78655-1_14 · Cited by 3
Bgh/GelMA/CMCS hydrogel with bone MSC-EVs for lunate defect repair
Li, M., Hu, H., Liu, L., Tian, M., & Li, X. (2025) · Nanomedicine · doi:10.1080/17435889.2025.2513852 · Cited by 2
Analysis of the effects of importin α1 on the nuclear translocation of IL-1α in HeLa cells
Yamada, A., Wake, K., Imaoka, S., Motoyoshi, M., Yamamoto, T., & Asano, M. (2024) · Scientific Reports · doi:10.1038/s41598-024-51521-w · Cited by 2
Cancer immunotherapy via nucleic acid aptamers
Zahedipour, F., Majeed, M. A., Kesharwani, P., & Sahebkar, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-85881-6.00003-8 · Cited by 2
Wiggins, K. A., Pyrillou, K., Humphry, M., Butterworth, A. S., & Clarke, M. C. H. (2022) · Immunology · doi:10.1111/imm.13584 · Cited by 2
“IL-1α is canonically cleaved by calpain, which occurs upon necrosis in some cell types and significantly increases activity [9], whilst IL-1β is typically activated by caspase-1 after inflammasome engagement [10].”
BackgroundInfluentialSelf-citationYang, G. H., & Huang, Y. (2021) · Springer eBooks · doi:10.1007/978-981-33-4838-7_6 · Cited by 1
Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
Higueras, M. Á., Jiménez-García, L., Herranz, S., Hortelano, S., & Luque, A. (2017) · Journal of Visualized Experiments · doi:10.3791/55824 · Cited by 1
The Interplay between Transcription Factors and Epigenetic Modifications in Th2 Cells
Onodera, A., Kokubo, K., & Nakayama, T. (2018) · InTech eBooks · doi:10.5772/intechopen.73027 · Cited by 1
Regulation of Immunity and Disease by the IL-1 Receptor Family Members IL-1R2 and IL-1R8
Molgora, M., Supino, D., & Garlanda, C. (2018) · Springer eBooks · doi:10.1007/978-3-319-77658-3_10 · Cited by 1
Land, W. G. (2020) · Springer eBooks · doi:10.1007/978-3-030-53868-2_3 · Cited by 1
Frontiers in Clinical Drug Research - Alzheimer Disorders
Atta-ur-rahman, Mavoungou, C., Zimmerman, K. S., Wright, J., Harding, J., Cavallaro, R., Fuso, A., Yoshiyama, Y., Asija, Z., Clifford, A., et al. (2015) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/97816810806801150301 · Cited by 1
Jones, D. (2014) · doi:10.18297/etd/1745 · Cited by 1
“lymphocyte, macrophage), as shown in Figure 3 [139, 141, 142].”
BackgroundInterleukin-1 Receptor Antagonist: A Promising Cytosine In Human Squamous Epithelial Cell CarcinomaPreprint
Ding, Y., Yi, J., Wang, J., & Sun, Z. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4192428 · Cited by 1
Garlanda, C., Ceglie, I. D., & Jaillon, S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-824465-4.00178-2 · Cited by 1
The IL-1 family in relation to psoriasis
Doble, R. (2014) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Lage, S. L. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2016.tde-25022016-095353
The Function of IL-1α a Typical Alarmin
Asano, M. (2020) · Japanese Journal of Oral Diagnosis / Oral Medicine · doi:10.15214/jsodom.33.189
Visagie, M. H. (2014) · UpSpace Institutional Repository (University of Pretoria)
Ejes inflamatorios y alarminas en el intestino delgado en enfermedad celíaca
Pérez, F. (2021) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · doi:10.35537/10915/129881
Research Progress of Different Inflammatory Factors in Osteoporosis
卢, 锋. (2022) · Advances in Clinical Medicine · doi:10.12677/acm.2022.124373
Karsalari, P. D., Asnaashari, K., & Rezaei, N. (2025) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2025.2500425
“Furthermore, IL-1 engages with adjacent cells to upregulate adhesion molecules and inflammatory cytokine and chemokine release such as IL-6, CXCL8 (IL-8), and CCL20 to augment more immune cells, leading to alloreactivity [164–166].”
Grytting, V. S., Refsnes, M., Øvrevik, J., Halle, M. S., Schönenberger, J., van der Lelij, R., Snilsberg, B., Skuland, T., Blom, R., & Låg, M. (2021) · Figshare · doi:10.6084/m9.figshare.14552102
Defining the boundaries of a healthy immune response using standardized immune monitoring tools
Urrutia, A. (2017) · theses.fr (ABES) · doi:10.70675/ab3d67edz85e0z4bb0za3a8z4ce8116e8156
“…cytokines such as interferon-alpha (IFN-a), interferon-beta (IFN-b), interferon-gamma (IFN-g), tumor necrosis factor-alpha (TNF-a), interleukin 1-beta (IL-1b), and interleukin 23 (IL-23) (Dinarello, 2012; González-Navajas et al., 2012; Oppmann et al., 2000; Platanias, 2005; Zheng et al., 2013).”
Plasticité cellulaire et initiation tumorale dans le modèle du cancer du sein
Blander, H. D. (2020) · theses.fr (ABES) · doi:10.70675/c6b4eda8z19a5z4b3dzb7d9zacc5fd814b21
Metadata
- Authors
- Zheng, Y., Humphry, M., Maguire, J. J., Bennett, M. R., & Clarke, M. C. H.
- Affiliations
- University of Cambridge (GB)
- Corresponding author
- Clarke, Murray C.H.
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2013-02
- Volume
- 38
- Issue
- 2
- Pages
- 285-295
- ISSN
- 1074-7613 (ISSN-L)
- PMC
- PMC3659285
- OpenAlex
- W2038182824
- Cited by
- 205
- References
- 54
- Citations by year
- 2026: 6 · 2025: 10 · 2024: 15 · 2023: 11 · 2022: 18 · 2021: 15 · 2020: 6 · 2019: 14 · 2018: 15 · 2017: 17 · 2016: 18 · 2015: 20 · 2014: 18 · 2013: 22
- FWCI
- 11.65
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Immunity (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Apollo (University of Cambridge) (submittedVersion, cc-by-nc-nd)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Apollo (cc-by)
- Funders
- National Institute for Health and Care Research
- British Heart Foundation (RG/08/009/25841, PG/06/024/20354, FS/13/3/30038, RG04/001, FS/09/005/26845)
- NIHR Cambridge Biomedical Research Centre
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Keywords
- interleukin-1 alpha, interleukin-1 receptor 2, sterile inflammation, necrosis, caspase-1, calpain, IL-1 receptor 1, damage-associated molecular patterns
- MeSH terms
- Animals, Calpain, Cell Line, Gene Expression Regulation, Humans, Inflammation, Necrosis, Organ Specificity, Protein Binding, Protein Precursors, Signal Transduction, Caspase 1, Mice, Receptors, Interleukin-1 Type II, Interleukin-1alpha, Proteolysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review